Cargando…
A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
Hepatitis A virus (HAV) and hepatitis E virus (HEV) are causative agents of acute viral hepatitis transmitted via the fecal–oral route. Both viruses place a heavy burden on the public health and economy of developing countries. To test the possibility that HAV could be used as an expression vector f...
Autores principales: | Kui, Xiang, Yuri, Kusov, Guan, Ying, Wang, Yan, Yi, Shan, Wu, Jinyuan, Yin, Na, Zhou, Yan, Li, Hongjun, Sun, Maosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618026/ https://www.ncbi.nlm.nih.gov/pubmed/28914805 http://dx.doi.org/10.3390/v9090260 |
Ejemplares similares
-
Prevalence of HAV and HEV in the patients presenting with acute viral hepatitis
por: Rao, Pooja, et al.
Publicado: (2012) -
Viability RT-qPCR to Distinguish Between HEV and HAV With Intact and Altered Capsids
por: Randazzo, Walter, et al.
Publicado: (2018) -
2509. Association of Non-Alcoholic Fatty Liver Disease with HBV, HAV, and HEV Exposure
por: Vassilopoulos, Stephanos, et al.
Publicado: (2023) -
Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018) -
The Medicinal Chemistry of Antihepatitis Agents I: Anti-HAV, Anti-HDV, and Anti-HEV Agents
por: Gupta, Satya P.
Publicado: (2018)